Identification of potent and selective N-myristoyltransferase inhibitors of Plasmodium vivax liver stage hypnozoites and schizonts.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
05 09 2023
Historique:
received: 07 04 2023
accepted: 22 08 2023
medline: 7 9 2023
pubmed: 6 9 2023
entrez: 5 9 2023
Statut: epublish

Résumé

Drugs targeting multiple stages of the Plasmodium vivax life cycle are needed to reduce the health and economic burdens caused by malaria worldwide. N-myristoyltransferase (NMT) is an essential eukaryotic enzyme and a validated drug target for combating malaria. However, previous PvNMT inhibitors have failed due to their low selectivity over human NMTs. Herein, we apply a structure-guided hybridization approach combining chemical moieties of previously reported NMT inhibitors to develop the next generation of PvNMT inhibitors. A high-resolution crystal structure of PvNMT bound to a representative selective hybrid compound reveals a unique binding site architecture that includes a selective conformation of a key tyrosine residue. The hybridized compounds significantly decrease P. falciparum blood-stage parasite load and consistently exhibit dose-dependent inhibition of P. vivax liver stage schizonts and hypnozoites. Our data demonstrate that hybridized NMT inhibitors can be multistage antimalarials, targeting dormant and developing forms of liver and blood stage.

Identifiants

pubmed: 37669940
doi: 10.1038/s41467-023-41119-7
pii: 10.1038/s41467-023-41119-7
pmc: PMC10480161
doi:

Substances chimiques

glycylpeptide N-tetradecanoyltransferase EC 2.3.1.97
Acyltransferases EC 2.3.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

5408

Informations de copyright

© 2023. Springer Nature Limited.

Références

PLoS Negl Trop Dis. 2012;6(4):e1625
pubmed: 22545171
J Med Chem. 2014 Mar 27;57(6):2773-88
pubmed: 24641010
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
J Med Chem. 2012 Apr 12;55(7):3578-82
pubmed: 22439843
Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):79-87
pubmed: 18165478
Cell Host Microbe. 2015 Apr 8;17(4):526-35
pubmed: 25800544
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011 Sep 1;67(Pt 9):1010-4
pubmed: 21904042
Protein Expr Purif. 2005 May;41(1):207-34
pubmed: 15915565
Infect Disord Drug Targets. 2009 Nov;9(5):493-506
pubmed: 19594426
Nat Chem. 2018 Jun;10(6):599-606
pubmed: 29760414
Nat Chem Biol. 2018 Jul;14(7):671-679
pubmed: 29892081
IUCrJ. 2014 Jun 17;1(Pt 4):250-60
pubmed: 25075346
EMBO J. 2004 Feb 25;23(4):712-8
pubmed: 14765114
Science. 1985 Jan 25;227(4685):427-9
pubmed: 3917576
J Med Chem. 2013 Jan 10;56(1):371-5
pubmed: 23170970
ACS Infect Dis. 2021 Oct 8;7(10):2764-2776
pubmed: 34523908
Malar J. 2018 Dec 10;17(1):462
pubmed: 30526594
Struct Dyn. 2019 Nov 22;6(6):064301
pubmed: 31768399
Nat Commun. 2020 Feb 26;11(1):1067
pubmed: 32103017
Nat Chem. 2014 Feb;6(2):112-21
pubmed: 24451586
J Med Chem. 2012 Oct 25;55(20):8879-90
pubmed: 23035716
Org Biomol Chem. 2014 Nov 7;12(41):8132-7
pubmed: 25230674
J Med Chem. 2020 Jan 23;63(2):591-600
pubmed: 31850752
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Cell Host Microbe. 2018 Mar 14;23(3):395-406.e4
pubmed: 29478773
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011 Sep 1;67(Pt 9):998-1005
pubmed: 21904040
ACS Infect Dis. 2018 Apr 13;4(4):449-457
pubmed: 29363940
Anal Biochem. 2012 Feb 1;421(1):342-4
pubmed: 22051857
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
PLoS Med. 2015 Oct 27;12(10):e1001891
pubmed: 26505753
Cell Microbiol. 2017 Aug;19(8):
pubmed: 28256794
Methods Enzymol. 1997;276:307-26
pubmed: 27754618
Cancer Res. 2017 Dec 15;77(24):6950-6962
pubmed: 29038344
Elife. 2018 Dec 27;7:
pubmed: 30589413
Malar J. 2017 Jan 13;16(1):26
pubmed: 28086874
Trends Parasitol. 2015 Jun;31(6):239-45
pubmed: 25816801
Nat Commun. 2020 Feb 28;11(1):1132
pubmed: 32111831
J Biol Chem. 1998 Oct 2;273(40):25864-74
pubmed: 9748261
Trends Parasitol. 2017 Apr;33(4):260-263
pubmed: 28077251
Nat Commun. 2018 May 9;9(1):1837
pubmed: 29743474
Cell Chem Biol. 2019 Jul 18;26(7):991-1000.e7
pubmed: 31080074
Science. 2019 Jul 5;365(6448):
pubmed: 31273098
Medchemcomm. 2017 Jan 1;8(1):191-197
pubmed: 28626547
Cell Chem Biol. 2020 Jun 18;27(6):719-727.e5
pubmed: 32330444
Malar J. 2019 Mar 22;18(1):93
pubmed: 30902052
Chem Rev. 2021 Sep 8;121(17):10452-10468
pubmed: 34197083
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
J Med Chem. 2020 Mar 12;63(5):2095-2113
pubmed: 31423787
Elife. 2017 Dec 07;6:
pubmed: 29215331
Nat Commun. 2014 Sep 26;5:4919
pubmed: 25255805
PLoS Med. 2021 Apr 23;18(4):e1003561
pubmed: 33891587
Org Lett. 2012 Aug 3;14(15):3886-9
pubmed: 22799458
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Science. 2018 May 4;360(6388):
pubmed: 29724925
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011 Sep 1;67(Pt 9):979-84
pubmed: 21904037
PLoS Biol. 2021 Oct 25;19(10):e3001408
pubmed: 34695132
Medchemcomm. 2015 Oct 8;6(10):1767-1772
pubmed: 26962430
Proc Natl Acad Sci U S A. 1990 Jan;87(2):728-32
pubmed: 2153964

Auteurs

Diego Rodríguez-Hernández (D)

Department of Chemistry and Molecular Biology, University of Gothenburg; S-405 30, Gothenburg, Sweden.
Department of Chemistry, University of Bergen, Allegaten 41, NO-5007, Bergen, Norway.

Kamalakannan Vijayan (K)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, 98109, USA.
School of Biology, Indian Institute of Science Education and Research, Thiruvananthapuram, Kerala, 695551, India.

Rachael Zigweid (R)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, 98109, USA.
Seattle Structural Genomics Center for Infectious Disease, Seattle, WA, 98109, USA.

Michael K Fenwick (MK)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, 98109, USA.
Seattle Structural Genomics Center for Infectious Disease, Seattle, WA, 98109, USA.

Banumathi Sankaran (B)

Molecular Biophysics and Integrated Bioimaging, Berkeley Center for Structural Biology, Advanced Light Source; Berkeley National Laboratory, Berkeley, CA, 94720, USA.

Wanlapa Roobsoong (W)

Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400, Thailand.

Jetsumon Sattabongkot (J)

Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400, Thailand.

Elizabeth K K Glennon (EKK)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, 98109, USA.

Peter J Myler (PJ)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, 98109, USA.
Seattle Structural Genomics Center for Infectious Disease, Seattle, WA, 98109, USA.
Department of Pediatrics, University of Washington, Seattle, WA, 98195, USA.

Per Sunnerhagen (P)

Department of Chemistry and Molecular Biology, University of Gothenburg; S-405 30, Gothenburg, Sweden.

Bart L Staker (BL)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, 98109, USA.
Seattle Structural Genomics Center for Infectious Disease, Seattle, WA, 98109, USA.

Alexis Kaushansky (A)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, 98109, USA. Alexis.Kaushansky@seattlechildrens.org.
Department of Pediatrics, University of Washington, Seattle, WA, 98195, USA. Alexis.Kaushansky@seattlechildrens.org.

Morten Grøtli (M)

Department of Chemistry and Molecular Biology, University of Gothenburg; S-405 30, Gothenburg, Sweden. grotli@chem.gu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH